Utah Medical Products Price to Sales Ratio 2010-2025 | UTMD
Historical PS ratio values for Utah Medical Products (UTMD) over the last 10 years. The current P/S ratio for Utah Medical Products as of July 01, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Utah Medical Products P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-01 | 57.36 | 5.05 | |
| 2025-03-31 | 55.73 | $11.37 | 4.90 |
| 2024-12-31 | 60.80 | $11.57 | 5.26 |
| 2024-09-30 | 65.86 | $12.35 | 5.33 |
| 2024-06-30 | 65.48 | $12.91 | 5.07 |
| 2024-03-31 | 69.38 | $13.50 | 5.14 |
| 2023-12-31 | 81.82 | $13.81 | 5.93 |
| 2023-09-30 | 83.25 | $14.14 | 5.89 |
| 2023-06-30 | 89.91 | $14.27 | 6.30 |
| 2023-03-31 | 91.14 | $14.41 | 6.32 |
| 2022-12-31 | 96.37 | $14.33 | 6.72 |
| 2022-09-30 | 81.53 | $14.13 | 5.77 |
| 2022-06-30 | 81.82 | $14.01 | 5.84 |
| 2022-03-31 | 85.30 | $13.78 | 6.19 |
| 2021-12-31 | 94.61 | $13.41 | 7.05 |
| 2021-09-30 | 86.25 | $13.16 | 6.56 |
| 2021-06-30 | 78.76 | $12.59 | 6.26 |
| 2021-03-31 | 79.93 | $11.54 | 6.93 |
| 2020-12-31 | 77.57 | $11.47 | 6.76 |
| 2020-09-30 | 73.26 | $11.36 | 6.45 |
| 2020-06-30 | 81.00 | $11.84 | 6.84 |
| 2020-03-31 | 85.71 | $12.61 | 6.80 |
| 2019-12-31 | 98.02 | $12.55 | 7.81 |
| 2019-09-30 | 86.83 | $11.99 | 7.24 |
| 2019-06-30 | 86.46 | $11.41 | 7.57 |
| 2019-03-31 | 79.46 | $11.16 | 7.12 |
| 2018-12-31 | 74.56 | $11.20 | 6.66 |
| 2018-09-30 | 84.28 | $11.32 | 7.44 |
| 2018-06-30 | 98.27 | $11.26 | 8.72 |
| 2018-03-31 | 87.96 | $11.24 | 7.82 |
| 2017-12-31 | 72.22 | $11.09 | 6.51 |
| 2017-09-30 | 65.04 | $10.71 | 6.07 |
| 2017-06-30 | 63.79 | $10.56 | 6.04 |
| 2017-03-31 | 54.68 | $10.44 | 5.24 |
| 2016-12-31 | 63.58 | $10.42 | 6.10 |
| 2016-09-30 | 52.06 | $10.61 | 4.91 |
| 2016-06-30 | 54.62 | $10.69 | 5.11 |
| 2016-03-31 | 54.00 | $10.67 | 5.06 |
| 2015-12-31 | 50.33 | $10.65 | 4.73 |
| 2015-09-30 | 46.10 | $10.82 | 4.26 |
| 2015-06-30 | 50.79 | $11.03 | 4.61 |
| 2015-03-31 | 50.75 | $11.05 | 4.59 |
| 2014-12-31 | 50.69 | $10.94 | 4.64 |
| 2014-09-30 | 40.98 | $10.89 | 3.76 |
| 2014-06-30 | 43.02 | $10.70 | 4.02 |
| 2014-03-31 | 48.13 | $10.57 | 4.55 |
| 2013-12-31 | 47.36 | $10.74 | 4.41 |
| 2013-09-30 | 48.99 | $10.72 | 4.57 |
| 2013-06-30 | 44.54 | $10.88 | 4.09 |
| 2013-03-31 | 39.80 | $10.93 | 3.64 |
| 2012-12-31 | 29.27 | $11.22 | 2.61 |
| 2012-09-30 | 27.40 | $11.28 | 2.43 |
| 2012-06-30 | 26.84 | $11.43 | 2.35 |
| 2012-03-31 | 24.72 | $11.57 | 2.14 |
| 2011-12-31 | 21.29 | $10.39 | 2.05 |
| 2011-09-30 | 20.70 | $9.38 | 2.21 |
| 2011-06-30 | 20.34 | $8.13 | 2.50 |
| 2011-03-31 | 22.19 | $7.00 | 3.17 |
| 2010-12-31 | 20.45 | $6.90 | 2.97 |
| 2010-09-30 | 21.52 | $6.98 | 3.08 |
| 2010-06-30 | 18.18 | $7.11 | 2.56 |
| 2010-03-31 | 20.34 | $7.13 | 2.85 |
| 2009-12-31 | 21.03 | $7.15 | 2.94 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.185B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |